After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Taysha Gene Therapies Inc is $1.11B. A total of 3.3 million shares were traded on the day, compared to an average of 6.37M shares.
In the most recent transaction, Nagendran Sukumar sold 260,047 shares of TSHA for 4.51 per share on Dec 01 ’25. After the transaction, the President and Head of R&D now owns 1,006,439 company shares. In a previous transaction on Nov 28 ’25, Nagendran Sukumar sold 110,125 shares at 4.75 per share. TSHA shares that President and Head of R&D owns now total 1,006,439.
Among the insiders who bought shares, Nagendran Sukumar acquired of 370,172 shares on Nov 28 ’25 at a per-share price of $4.86. In another insider transaction, Rumana Haque-Ahmed bought 10,770 shares at $2.83 per share on Sep 22 ’25.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TSHA has a high of $5.51 and a low of $1.05.
As of this writing, TSHA has an earnings estimate of -$0.1 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.07 per share and a lower estimate of -$0.12. The company reported an EPS of -$0.07 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TSHA’s latest balance sheet shows that the firm has $149.10M in Cash & Short Term Investments as of fiscal 2021. There were $63.09M in debt and $51.75M in liabilities at the time. Its Book Value Per Share was $0.80, while its Total Shareholder’s Equity was $95.38M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TSHA is Buy with a score of 4.79.
